We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neuropsychological Testing Using Mobile Devices

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01776086
Recruitment Status : Withdrawn (no subjects agreed to participate)
First Posted : January 25, 2013
Last Update Posted : July 10, 2013
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this studying is to develop and characterize neuropsychological testing software for evaluating the prefrontal and temporal function of patients. As no software has been used for this purpose, this study will gather pilot data on the baseline performance of patients in a hospital setting that lack any neurological impairment. After creating this baseline, later experiments can be proposed to compare the performance in normal subjects with those who have neurologic injury or disease.

Condition or disease Intervention/treatment
Inpatients With Normal Neurological Function Behavioral: Neurological testing

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Neuropsychological Testing Using Mobile Devices
Study Start Date : January 2013
Estimated Primary Completion Date : July 2013
Estimated Study Completion Date : December 2013
Arms and Interventions

Arm Intervention/treatment
Normal patients
for patients with normal score on neurological testing with Folstein Mini-Mental Status Exam will then take the Scenes Task
Behavioral: Neurological testing
Other Names:
  • Scenes Task
  • Folstein Mini-Mental Status Exam


Outcome Measures

Primary Outcome Measures :
  1. Determination of "normal performance" curve [ Time Frame: 1 year ]
    The purpose of this study is to generate a curve of "normal performance" on the neurological test for hospitalized patients of different ages


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Inpatients > = 18 years of age
  • Patient must be able to provide informed consent

Exclusion Criteria:

  • Patients with score of < 26 on Folstein Mini-Mental Status Exam
  • Patients with known brain lesions
  • Patients with history of stroke, neurologic disease or dementia
  • Patients with acute illness or who are in imminent distress
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01776086


Locations
United States, New Jersey
Englewood Hospital and Medical Center
Englewood, New Jersey, United States, 07631
Sponsors and Collaborators
Englewood Hospital and Medical Center
Investigators
Principal Investigator: James Young, MD, PhD Englewood Hospital and Medical Center
More Information

Responsible Party: Englewood Hospital and Medical Center
ClinicalTrials.gov Identifier: NCT01776086     History of Changes
Other Study ID Numbers: E-12-471
First Posted: January 25, 2013    Key Record Dates
Last Update Posted: July 10, 2013
Last Verified: July 2013